Becton, Dickinson & Co. DL-Notes 2017(17/27)

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

4.67

Yield spread Bundesanleihe

1.9415

Tradable for private investors

No

Minimum amount tradeable unit

1,000.00

Maturity

06/06/2027

Interest Rate

3.70 %

Currency

US Dollar

Facts & figures

Price data

TRADE PLATFORM
LAST PRICE / YIELD99.248 G / 4.670 Units
PRICE DETERMINATION TIME07/27/2026 / 09:46:30 PM
DAILY VOLUME (NOMINAL)0
YIELD SPREAD1.9415
FIXINGPRICE-
DAILY HIGH / LOW99.2999.248
PREV. DAY'S PRICE99.246 (07/24)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW99.76 (02/06)98.63 (07/31)

Master Data

WKN
A19H77
ISIN
US075887BW84
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Corporate Bond
SUB-TYPEHealth Care
ISSUER
Becton Dickinson & Co.
S&P RATINGPlease log in to view this field
(TRADING) SEGMENT / TICKS
-/ -
TRADING HOURS
07:30:00 AM - 10:00:00 PM
INTEREST RATE
3.70 %
INTEREST RUN FROM
06/06/2017
NEXT INTEREST PAYMENT
06/06/2026
UNIT INTEREST FROM NOMINAL AMMOUNT
-
TRADING CURRENCY / NOTATION
US Dollar/ Percent
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
QUOTATION
Continuous trading
ISSUING VOLUME
2.40 Bil.
MINIMUM AMOUNT TRADEABLE UNIT
1,000.00
SMALLEST TRADEABLE UNIT
1,000.00
MATURITY
06/06/2027
MARKET MAKER
-
STEP UP/ DOWN WHEN RATING CHANGES
No
STEP UP FIXED AT ISSUE
No
STEP DOWN FIXED AT ISSUE
No
BOND CALLABLE BY THE ISSUER
Yes
BOND IS SUBORDINATED
No

Description

Local currency bond: USD. Make Whole Call Option. Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.